المؤلفون: Hendrikse, C. S.E., Theelen, P. M.M., van der Ploeg, P., Westgeest, H. M., Boere, I. A., Thijs, A. M.J., Ottevanger, P. B., van de Stolpe, A., Lambrechts, S., Bekkers, R. L.M., Piek, J. M.J.

المصدر: Hendrikse , C S E , Theelen , P M M , van der Ploeg , P , Westgeest , H M , Boere , I A , Thijs , A M J , Ottevanger , P B , van de Stolpe , A , Lambrechts , S , Bekkers , R L M & Piek , J M J 2023 , ' The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer : A systematic review and meta-analysis ' , Gynecologic Oncology , vol. 171 , pp. 83-94 . https://doi.org/10.1016/j.ygyno.2023.01.038Test

مصطلحات موضوعية: /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being

وصف الملف: application/pdf

العلاقة: https://pure.eur.nl/en/publications/a6825ade-9eca-44ad-8895-849e27b04b76Test

الإتاحة: https://doi.org/10.1016/j.ygyno.2023.01.038Test
https://pure.eur.nl/en/publications/a6825ade-9eca-44ad-8895-849e27b04b76Test
https://pure.eur.nl/ws/files/85669738/The_potential_of_RAS_RAF_MEKERK_MAPK_signaling_pathway_inhibitors_in_ovarian_cancer.pdfTest
http://www.scopus.com/inward/record.url?scp=85148715111&partnerID=8YFLogxKTest

المؤلفون: Hendrikse, C. S.E., Theelen, P. M.M., van der Ploeg, P., Westgeest, H. M., Boere, I. A., Thijs, A. M.J., Ottevanger, P. B., van de Stolpe, A., Lambrechts, S., Bekkers, R. L.M., Piek, J. M.J.

المصدر: Hendrikse , C S E , Theelen , P M M , van der Ploeg , P , Westgeest , H M , Boere , I A , Thijs , A M J , Ottevanger , P B , van de Stolpe , A , Lambrechts , S , Bekkers , R L M & Piek , J M J 2023 , ' The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer : A systematic review and meta-analysis ' , Gynecologic Oncology , vol. 171 , pp. 83-94 . https://doi.org/10.1016/j.ygyno.2023.01.038Test

مصطلحات موضوعية: /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being

وصف الملف: application/pdf

العلاقة: https://pure.eur.nl/en/publications/a6825ade-9eca-44ad-8895-849e27b04b76Test

الإتاحة: https://doi.org/10.1016/j.ygyno.2023.01.038Test
https://pure.eur.nl/en/publications/a6825ade-9eca-44ad-8895-849e27b04b76Test
https://pure.eur.nl/ws/files/85669738/The_potential_of_RAS_RAF_MEKERK_MAPK_signaling_pathway_inhibitors_in_ovarian_cancer.pdfTest
http://www.scopus.com/inward/record.url?scp=85148715111&partnerID=8YFLogxKTest

المؤلفون: Hendrikse, C.S.E., Theelen, P.M.M., van der Ploeg, P., Westgeest, H.M., Boere, I.A., Thijs, A.M.J., Ottevanger, P.B., van de Stolpe, A., Lambrechts, S., Bekkers, R.L.M., Piek, J.M.J.

المصدر: Hendrikse , C S E , Theelen , P M M , van der Ploeg , P , Westgeest , H M , Boere , I A , Thijs , A M J , Ottevanger , P B , van de Stolpe , A , Lambrechts , S , Bekkers , R L M & Piek , J M J 2023 , ' The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis ' , Gynecologic Oncology , vol. 171 , no. 1 , pp. 83-94 . https://doi.org/10.1016/j.ygyno.2023.01.038Test

مصطلحات موضوعية: MAPK pathway, MAPK inhibitors, Targeted therapy, Signal transduction pathway, Ovarian cancer, Clinical benefit, EPITHELIAL OVARIAN, PHASE-II, DOSE-ESCALATION, MEK INHIBITOR, DOUBLE-BLIND, HIGH-GRADE, COMBINATION, KINASE, BRAF, TRAMETINIB

العلاقة: https://cris.maastrichtuniversity.nl/en/publications/517abf66-a989-4315-913e-263e0f0235dfTest

الإتاحة: https://doi.org/10.1016/j.ygyno.2023.01.038Test
https://cris.maastrichtuniversity.nl/en/publications/517abf66-a989-4315-913e-263e0f0235dfTest

المؤلفون: Hendrikse, C.S.E., Theelen, P.M.M., van der Ploeg, P., Westgeest, H.M., Boere, I.A., Thijs, A.M.J., Ottevanger, P.B., van de Stolpe, A., Lambrechts, S., Bekkers, R.L.M., Piek, J.M.J.

المصدر: Gynecologic Oncology ; volume 171, page 83-94 ; ISSN 0090-8258

الإتاحة: https://doi.org/10.1016/j.ygyno.2023.01.038Test
https://api.elsevier.com/content/article/PII:S0090825823000549?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0090825823000549?httpAccept=text/plainTest

المؤلفون: Ploeg, P. van der, Hendrikse, C.S.E., Thijs, A.M.J., Westgeest, H.M., Smedts, H.P.M., Vos, M.C., Jalving, M., Lok, C. A. R., Boere, I.A., Ham, M.A.P.C. van, Ottevanger, N., Westermann, A.M., Mom, C.H., Lalisang, R.I., Lambrechts, S., Bekkers, R.L.M., Piek, J.M.J.

المصدر: Heliyon, 10, 1, pp. e23170

مصطلحات موضوعية: All institutes and research themes of the Radboud University Medical Center, Radboudumc 17: Women's cancers Gynaecology, Radboudumc 17: Women's cancers Medical Oncology

العلاقة: https://repository.ubn.ru.nl//bitstream/handle/2066/302033/302033.pdfTest; https://repository.ubn.ru.nl/handle/2066/302033Test

الإتاحة: https://doi.org/10.1016/j.heliyon.2023.e23170Test
https://repository.ubn.ru.nl//bitstream/handle/2066/302033/302033.pdfTest
https://repository.ubn.ru.nl/handle/2066/302033Test

المؤلفون: Ubachs, J., van de Worp, W.R.P.H., Vaes, R.D.W., Pasmans, K., Langen, R.C., Meex, R.C.R., van Bijnen, A.A.J.H.M., Lambrechts, S., Van Gorp, T., Kruitwagen, R.F.P.M., Damink, S.W.M.O., Rensen, S.S.

المصدر: Ubachs , J , van de Worp , W R P H , Vaes , R D W , Pasmans , K , Langen , R C , Meex , R C R , van Bijnen , A A J H M , Lambrechts , S , Van Gorp , T , Kruitwagen , R F P M , Damink , S W M O & Rensen , S S 2022 , ' Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients ' , Journal of cachexia, sarcopenia and muscle , vol. 13 , ....

مصطلحات موضوعية: Protein synthesis, Protein breakdown, Atrogenes, NF-kappa B, Interleukin-6, C2C12 cells, Myotubes, Translational research, UBIQUITIN LIGASES, CACHEXIA, CYTOKINES, SURVIVAL, ATROPHY, DIFFERENTIATION, ACTIVATION, EXPRESSION, PATHWAY, REDD1

الإتاحة: https://doi.org/10.1002/jcsm.12885Test
https://cris.maastrichtuniversity.nl/en/publications/52b768da-6b9e-4296-918e-17a8627f4fd0Test

المؤلفون: van der Ploeg, P., Uittenboogaard, A., Bucks, K.M.M., Lentjes-Beer, M.H.F.M., Bosch, S.L., van Rumste, M.M.E., Vos, M.C., van Diest, P.J., Lambrechts, S., van de Stolpe, A., Bekkers, R.L.M., Piek, J.M.J.

المصدر: van der Ploeg , P , Uittenboogaard , A , Bucks , K M M , Lentjes-Beer , M H F M , Bosch , S L , van Rumste , M M E , Vos , M C , van Diest , P J , Lambrechts , S , van de Stolpe , A , Bekkers , R L M & Piek , J M J 2022 , ' Cyclic activity of signal transduction pathways in fimbrial epithelium of the human fallopian tube ' , Acta Obstetricia et Gynecologica Scandinavica , vol. 101 , no. 2 , pp. ....

مصطلحات موضوعية: computational models, fimbriae, hormonal cycle, human fallopian tube, signal transduction pathways, CELL HEIGHT, EXPRESSION, CILIATION, ESTROGEN, OVIDUCT

الإتاحة: https://doi.org/10.1111/aogs.14306Test
https://cris.maastrichtuniversity.nl/en/publications/2321cd7e-f65a-4720-a207-d7a46e0b1994Test

المؤلفون: Laven, P, Kruitwagen, R, Lambrechts, S, Van Gorp, T, Slangen, B, Zusterzeel, P, Van Der Pol, J

المصدر: E-Posters

الإتاحة: https://doi.org/10.1136/ijgc-2021-igcs.273Test

المؤلفون: Laven, P, Kruitwagen, R, Lambrechts, S

المصدر: Poster

الإتاحة: https://doi.org/10.1136/ijgc-2020-igcs.82Test

المؤلفون: van der Ploeg, P., Uittenboogaard, A., Thijs, A.M.J., Westgeest, H.M., Boere, I.A., Lambrechts, S., van de Stolpe, A., Bekkers, R.L.M., Piek, J.M.J.

المصدر: van der Ploeg , P , Uittenboogaard , A , Thijs , A M J , Westgeest , H M , Boere , I A , Lambrechts , S , van de Stolpe , A , Bekkers , R L M & Piek , J M J 2021 , ' The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis ' , Gynecologic Oncology , vol. 163 , no. 2 , pp. 433-444 . https://doi.org/10.1016/j.ygyno.2021.07.008Test

مصطلحات موضوعية: Ovarian cancer, Phosphatidylinositol-3-kinase, Akt, Mammalian target of rapamycin, Signal transduction pathway, Targeted therapy, ADVANCED SOLID TUMORS, PHASE-I, PI3K PATHWAY, EPITHELIAL OVARIAN, DOSE-ESCALATION, 1ST-IN-HUMAN, TRIAL, MULTICENTER, MTOR, TEMSIROLIMUS

الإتاحة: https://doi.org/10.1016/j.ygyno.2021.07.008Test
https://cris.maastrichtuniversity.nl/en/publications/1cb433d6-e52a-4ee4-823d-8a951ec93922Test